Drug details

Vumerity (diroximel fumarate delayed-release capsules)

type of Immunomodulators

Vumerity (diroximel fumarate) is a prescription medicine used to treat people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.

The following drugs are related to Vumerity, either as a replacement or used together:

• Lemtrada (alemtuzumab injection for intravenous infusion)
• Aubagio (teriflunomide tablets)
• Avonex (interferon beta-1a)
• Fleqsuvy (baclofen oral suspension)
• Bafiertam (monomethyl fumarate delayed-release capsules)
• Briumvi (ublituximab-xiiy injection)
• Tecfidera (dimethyl fumarate delayed release capsules)
• Gilenya (fingolimod capsules)
• Rebif (interferon beta-1a)
• Kesimpta (ofatumumab injection)
• Tysabri (natalizumab)
• Tyruko (natalizumab-sztn injection)
• Ocrevus (ocrelizumab injection)
• Zeposia (ozanimod capsules)
• Plegridy (peginterferon beta-1a injection for subcutaneous use)
• Ponvory (ponesimod tablets)